Liquid biopsy for breast cancer and other solid tumors: a review of recent advances
Breast Cancer · 2025
DOI: 10.1007/s12282-024-01556-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer, 2025. Verfasst von Hirofumi Ohmura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Ja…. Hauptthemen laut MEDLINE: Breast Neoplasms, Circulating Tumor DNA, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 86 Literaturangaben.
Abstract (Originalsprache)
Liquid biopsy using circulating tumor DNA (ctDNA) has been reported to be less invasive and effective for comprehensive genetic analysis of heterogeneous solid tumors, including decision-making for therapeutic strategies, predicting recurrence, and detecting genetic factors related to treatment resistance in various types of cancers. Breast cancer, colorectal cancer, and lung cancer are among the most prevalent malignancies worldwide, and clinical studies of liquid biopsy for these cancers are ongoing. Liquid biopsy has been used as a companion diagnostic tool in clinical settings, and research findings have accumulated, especially in cases of colorectal cancer after curative resection and non-small cell lung cancer (NSCLC) after curative chemoradiotherapy, in which ctDNA detection helps predict eligibility for adjuvant chemotherapy. Liquid biopsy using ctDNA shows promise across a wide range of cancer types, including breast cancer, and its clinical applications are expected to expand further through ongoing research. In this article, studies on liquid biopsy in breast cancer, colorectal cancer, and NSCLC are compared focusing on ctDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
- Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
- Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
- Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan.
- Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. baba.eishi.889@m.kyushu-u.ac.jp.
Zitieren
APA
Ohmura, H., Hanamura, F., Okumura, Y., Ando, Y., Masuda, T., Mimori, K., Akashi, K., & Baba, E. (2025). Liquid biopsy for breast cancer and other solid tumors: a review of recent advances. Breast Cancer. https://doi.org/10.1007/s12282-024-01556-8
Vancouver
Ohmura H, Hanamura F, Okumura Y, Ando Y, Masuda T, Mimori K, et al. Liquid biopsy for breast cancer and other solid tumors: a review of recent advances. Breast Cancer. 2025. doi:10.1007/s12282-024-01556-8
BibTeX
@article{Ohmura2025,
author = {Ohmura, Hirofumi and Hanamura, Fumiyasu and Okumura, Yuta and Ando, Yuki and Masuda, Takaaki and Mimori, Koshi and Akashi, Koichi and Baba, Eishi},
title = {Liquid biopsy for breast cancer and other solid tumors: a review of recent advances},
journal = {Breast Cancer},
year = {2025},
doi = {10.1007/s12282-024-01556-8}
}
EUVIMED